Jim Tananbaum possesses a lot of knowledge and experience in the healthcare sector. He has handled both private and public healthcare companies. Close to three decades ago, Jim Tananbaum made a resolve to base his business ventures in the healthcare industry. Through strategic partnerships, Jim has been able to create some of the most successful ventures in the field of medicine. His expertise in raising capital puts him ahead of his peers and enables him to pioneer some of the most ambitious medical research projects. For over 25 years, Jim Tananbaum has been the chief architect of management and financial strategies for Foresite Capital.
With a never ending quest of providing solutions to some of the humanity’s most stubborn medical conditions, Jim has been able to create enterprises that design tailored therapies for patients across the medical industry. Some of the pharmaceutical firms that Jim has either founded or helped in founding include GelTex Pharmaceuticals, Theravance, Amira Pharmaceuticals and Prospect Venture Partners.
Other than his glowing business career, Jim Tananbaum is academically gifted. His love for academics has seen him pursue the very heights of education. Jim is a proud holder of BS/BSEE degrees from the prestigious University of Yale, an M.D. and M.B.A. from the Ivy League College, Harvard, and an M.B.A from MIT.
Every year, Forbes acknowledges some of the most influential venture capitalists of that year on its Forbes Midas List. This list documents top 100 business people who have recorded significant earnings in their investments. Jim is currently listed number 52 on this list. This recognition goes a long way in emphasizing the critical role that Foresite Capital plays in the medical industry. Under Jim Tananbaum’s stewardship, the growth of Foresite Capital can only keep rising. You can visit Medium for more info.
Recently, Jim decided to add a venture partner to Foresite Capital. Dr. Molly who has a lot of experience in corporate America and the medical industry is expected to advance research and pharmaceutical development at Foresite. Mr. Jim is confident that Dr. Molly brings with her a lot of expertise and eloquence to the family of Foresite Capital.
Growth at Foresite Capital is on a steady upward curve is given that the firm has substantially increased its shares in Nanostring Technologies Inc., (NASDAQ: NSTG).
Check out his website About.me